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SUMMARY
Nematodes are amongst the most successful and abundant organisms on the planet with approximately 30000 species
described, although the actual number of species is estimated to be one million or more. Despite sharing a relatively simple
and invariant body plan, there is considerable diversity within the phylum. Nematodes have evolved to colonize most
ecological niches, and can be free-living or can parasitize plants or animals to the detriment of the host organism. In this
review we consider the role of heat shock protein 90 (Hsp90) in the nematode life cycle. We describe studies onHsp90 in the
free-living nematode Caenorhabditis elegans and comparative work on the parasitic species Brugia pahangi, and consider
whether a dependence upon Hsp90 can be exploited for the control of parasitic species.
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INTRODUCTION
The majority of nematodes are free-living, playing
important roles in ecosystemhealth and diversity, but
many are important and proliﬁc parasites. For an idea
of scale, approximately half the world’s population,
predominantly in tropical regions, harbour a nema-
tode infection (www.nematode.net). These worms
typically cause chronic infections that contribute
signiﬁcantly to morbidity, but rarely kill their hosts.
The most abundant parasitic species are gastrointes-
tinal nematodes such as Ascaris lumbricoides, which
infects an estimated 807 million, closely followed by
Trichuris trichiura (infecting an estimated 604 mil-
lion) and the hookworms (infecting approximately
576 million) (http://www.cdc.gov/parasites/). These
infections are often particularly prevalent and clini-
cally important in children. Filarial nematodes are
tissue-dwelling worms that account for an additional
157 million infections and are the causative agents
of river blindness (Onchocerca volvulus) and elephan-
tiasis (Wuchereria bancrofti and Brugia spp.). In
addition to their importance as human pathogens,
around 10% of global crop loss is due to plant
parasitic nematodes (Nicol et al. 2011), while
nematode parasites of livestock cause major economic
production losses to grazing ruminants. Currently,
infection is controlled by the use of anthelmintic
drugs. However, anthelmintic resistance, particularly
in nematodes of small ruminants such as sheep and
goats, is endemic in most countries (Gilleard, 2006).
Given that the same anthelmintic drugs are used in
mass administration campaigns to treat human
nematode infection, there is concern over the possible
development of resistance in human nematodes
(Vercruysse et al. 2012), underscoring the need for
the development of new drugs to control these
pathogens (Geary et al. 2010). In this review, we
focus on the role of Hsp90 in both free-living and
parasitic nematodes, speciﬁcally Caenorhabditis ele-
gans andBrugia spp. (life cycles of which are outlined
in Fig. 1) and discuss the potential of Hsp90 as a drug
target for the treatment of some helminth infections.
NEMATODE GENOMES
Analysis of nematode phylogeny based on the
small subunit ribosomal DNA sequences divided
the phylum into ﬁve clades: Dorylaimia (Clade I),
Enoplia (Clade II), Spurina (Clade III), Tylenchina
(Clade IV) and Rhabditina (Clade V), each contain-
ing parasitic species (Blaxter et al. 1998). The free-
living model organism C. elegans belongs to clade V,
along with many important parasitic species of
humans and animals, while ﬁlarial nematodes and
Ascaris belong to clade III. C. elegans is commonly
used to study the fundamental principles of biology
and for understandingmechanisms of human disease,
as well as acting as a model for parasitic nematodes
(Kirienko et al. 2010; Hashmi et al. 2013; Li and Le,
2013). In 1998, the sequencing of the C. elegans
genome heralded a new era of whole-organism
research, and inspired other nematode genome
sequencing projects. Draft genome sequences are
now available for a range of parasitic species
including Brugia malayi (Ghedin et al. 2007),
Ascaris suum (Jex et al. 2011), Trichinella spiralis
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(Mitreva et al. 2011),Diroﬁlaria immitis (Godel et al.
2012), Haemonchus contortus (Laing et al. 2013;
Schwarz et al. 2013), Loa loa (Desjardins et al.
2013), Necator americanus (Tang et al. 2014) and the
plant parasitic nematodes Melodoigyne incognita
(Abad et al. 2008), Meloidogyne hapla (Opperman
et al. 2008), as well as the necromenic species
Pristionchus paciﬁcus (Dieterich et al. 2008; Rae
et al. 2008) and additional Caenorhabditis species
(Stein et al. 2003). In addition, the 50 helminth
genomes project coordinated by the Wellcome Trust
Sanger Institute aims to provide draft genomes for 50
helminths, including many important parasitic ne-
matodes (see www.sanger.ac.uk/research/initiatives/
globalhealth/research/helminthgenomes/).
Furthermore, there are databases of expressed se-
quence tags (ESTs), which have proved to be very
useful in establishing a catalogue of the mRNA
transcripts expressed in various species and in
diﬀerent life cycle stages. Access to ESTs can be
found in various online databases, the most extensive
of which is NEMBASE4 (http://www.nematodes.
org/nembase4/) which reports on over 223000
nematode genes across >60 species. Nematode trans-
criptomics (RNA sequencing) is set to blossom in the
coming years with the advent of next generation
sequencing with high throughput at signiﬁcantly
lower cost, thus enabling the production of large
datasets. The comparative analysis of multiple
nematode genomes should facilitate the identiﬁcation
of candidate genes of interest and hopefully lead to
new drug targets for many nematode pathogens.
HSP90 IN NEMATODES
Hsp90 is a highly conserved molecule across all
species. For example, Hsp90 from B. malayi and
Brugia pahangi are 99·9% identical. Hsp90 from
humans and Brugia spp. share 77% identity, while
Hsp90 from C. elegans and Brugia spp. are 84%
identical. Despite this level of conservation, the
function of Hsp90 seems to vary between diﬀerent
nematode species, as it does between normal and
malignant mammalian cells (Kamal et al. 2003). The
ﬁrst indication that some nematodes may possess an
atypical Hsp90 came from a study that demonstrated
that C. elegans Hsp90 (DAF-21) was unable to bind
to geldanamycin (GA), the prototype Hsp90 inhibi-
tor (David et al. 2003). DAF-21 is clearly required in
C. elegans, as demonstrated by the arrested pheno-
type of a loss of function mutant (Birnby et al. 2000).
However, attempts to chemically inhibit DAF-21 by
growth of the nematode on plates containing high
levels of GA or by feeding worms on cultures of
Streptomyces hygroscopicus (the actinomycete which
synthesizes GA), produced no obvious phenotype
Fig. 1. Life cycle of the free-living nematode C. elegans and the parasitic lymphatic ﬁlarial nematodes. The normal
hermaphroditic life cycle of C. elegans (A) takes approximately 3 days. Eggs are fertilized within the adult and after
laying, hatch and worms proceed through four larval stages, each of which ends in a moult. Each adult will lay
approximately 300 eggs and live for approximately 2 weeks. Under adverse conditions (i.e. lack of food, unfavourable
temperatures or overcrowding), C. elegans can enter an alternative pathway called ‘dauer’. In this state, worms can
remain dormant for 3 months and can re-enter the life cycle when the environment becomes favourable. All the
lymphatic ﬁlarial nematodes share an invariant life cycle (B). The full developmental cycle takes place in the mosquito
(the intermediate host) or the human (the deﬁnitive host). Infection of the deﬁnitive host is initiated by the bite of a
mosquito harbouring the infective L3. The L3 enters the body via the puncture site and migrates to the lymphatic
system of the mammalian host. L3 moult through L4 to become sexually mature adult male and female worms, which
have a lifespan of approximately 8 years. After sexual reproduction the female worms release microﬁlariae (Mf, ﬁrst stage
larvae), which migrate to the bloodstream and are available for ingestion by a mosquito taking a blood meal.
Development from Mf to the L3 stage within the mosquito occurs in the thoracic muscles and is a temperature-
dependent process (optimal 28 °C and 80% humidity). Mature L3 migrate to the feeding structures in the head of the
mosquito, which facilitates their transmission to the deﬁnitive host. It should be noted that other species of parasitic
nematode do not require an arthropod intermediate host and have ‘free-living’ stages, where they are present in the
environment in an infective form. The schematic presented above refers to lymphatic ﬁlarial parasites only.
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(David et al. 2003). A subsequent survey of Hsp90 in
24 diﬀerent nematode species demonstrated that C.
elegans DAF-21 was not unique in this respect (Him
et al. 2009). Using extracts of a variety of free-living
and parasitic nematodes, it was shown that the ability
to bind GA was associated with the life history of
a particular species. Nematodes that are obligate
parasites or those that live in the environment
enclosed within an egg were able to bind GA; in
contrast, free-living species and those with free-living
larval stages did not bind GA (summarized in Fig. 2).
This analysis is consistent with the adaptive evol-
ution hypothesis proposed by David et al. in their
original paper. Streptomyces hygroscopicus is a soil-
dwelling species and thus nematodes with free-living
stages in the environment may be exposed to GA or
similar inhibitors during their life cycle, driving the
evolution of a GA-resistant form of Hsp90. To
further test this hypothesis, the amino acid sequences
of Hsp90 from 15 species of nematodes were
compared to determine if any of the GA-resistant
strains showed evidence of adaptive Darwinian
evolution. Although there was evidence of rapid
diversifying evolution of hsp90 along three separate
nematode lineages, no evidence was found for amino
acid changes that correlated with a change in GA-
binding (Him et al. 2009). Thus the rapid evolution
of the hsp90 gene is presumably associated with some
other important function, given its multifaceted role
within the cell.
Studies using chimeric Hsp90 molecules demon-
strated that the inability ofC. elegansDAF-21 to bind
GA was associated with the N-terminal region
(David et al. 2003). GA is a natural product of
S. hygroscopicus and studies on this organism and on
other microbes that produce Hsp90 inhibitors, have
cast some light upon the adaptive mechanisms
by which these organisms avoid self-toxicity.
A combination of elegant structural and mutational
studies inS. hygroscopicus (Millson et al. 2011) and in
the fungus, Humicola fuscoatra, which synthesizes
the Hsp90 inhibitor Radicicol, demonstrated the
importance of naturally occurring amino acid sub-
stitutions in the N-terminal domain of Hsp90,
which alter the binding of the appropriate drug.
For H. fuscoatra, a single leucine to isoleucine
substitution (L34I) within the N-terminal binding
pocket of Hsp90 signiﬁcantly altered the binding of
Radicicol, while retaining the ability to bind GA and
ATP and its chaperone activity (Prodromou et al.
2009). These studies raise the question of whether
such evolutionary pressures can result in similar
mutations within hsp90 of higher organisms. Despite
its widespread use as a model organism, our under-
standing of the ecology of C. elegans in the wild
remains patchy: does C. elegans live in the same
ecological niche as inhibitor-producing microbes in
nature? A recent study surveyed the bioavailability
of over 1000 drug-like molecules in C. elegans and
demonstrated that many molecules fail to accumulate
in the worm and thus have no apparent activity
(Burns et al. 2010), further suggesting that protection
against toxins could be a credible selection pressure.
However, while this phenomenon may contribute to
the lack of activity of Hsp90 inhibitors on C. elegans,
it does not explain the inability of DAF-21 to bind to
Hsp90 inhibitors in soluble extracts.
FUNCTIONAL STUDIES ON HSP90 IN C. ELEGANS
Hsp90 has been well characterized in yeast and
cultured mammalian cell lines, as an ATP-depen-
dent, ubiquitous, molecular chaperone, which inter-
acts with multiple ‘client’ proteins; these are proteins
which require the activity of Hsp90 for folding
or stability. However, much less is known about the
cellular function of Hsp90 in the complete metazoan.
Fig. 2. Outline of nematode species and GA-binding properties. Extracts of nematodes were incubated with GA beads
and pull-downs analysed by SDS-PAGE and immune-blotting. Details in Him et al. (2009).
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Inevitably, much of our understanding of the role of
Hsp90 in nematodes comes from work on C. elegans.
This free-living nematode is easily maintained in the
laboratory setting, unlike parasitic species, which
often have complex life cycles involving intermediate
and deﬁnitive hosts and/or stages that develop in the
environment (summarized in Fig. 1). The life cycle
of C. elegans takes only 3 days and, additionally, a
range of powerful molecular techniques such as RNA
interference (RNAi), mutagenesis and transgenesis,
can be employed in C. elegans, whereas the appli-
cation of such methods to most parasitic nematodes is
in its infancy.
Mammals and yeast contain two isoforms of
Hsp90 present in the cytosol, while in C. elegans
there is a single hsp90 orthologue, known as daf-21,
located on chromosome V. Worms with a loss of
function mutation in daf-21 arrest at the L2–L3 stage
(Birnby et al. 2000) conﬁrming the requirement
for wild type DAF-21 in life cycle progression in
C. elegans. Early studies demonstrated thatC. elegans
underwent a classical heat shock response following
exposure to elevated temperature, with the induction
of a number of genes, particularly those encoding
small Hsps (Candido et al. 1989; Jones et al. 1989).
The expression of most Hsps in response to elevated
temperature is regulated by heat shock factor (HSF-
1), a transcription factor that binds to conserved heat
shock elements in the upstream region of Hsp genes
(Wu, 1995). However, in C. elegans knock-down of
hsf-1 by RNAi had minimal eﬀect upon the levels of
DAF-21 in nematodes exposed to heat shock, while
signiﬁcantly decreasing the expression of the small
Hsp, Hsp-16 (Walker et al. 2003). These data suggest
that daf-21 expression may be regulated by factors
other than the classic HSF-1. Interestingly, previous
studies had shown that daf-21 was up-regulated
15-fold in dauer larvae, an alternative developmental
stage that C. elegans can enter upon encountering
unfavourable conditions, such as overcrowding or
lack of food. Dauer larvae are stress-resistant and
long-lived. Entry into, and recovery from, the dauer
stage is regulated by levels of a pheromone produced
by the worms (Golden and Riddle, 1982). When
worms were stimulated to exit the dauer stage, levels
of daf-21 mRNA declined rapidly (Dalley and
Golomb, 1992). Similar ﬁndings were reported by
Jones et al. (2001) who showed that the expression of
daf-21 was up-regulated in the dauer stage compared
with mixed life cycle stages, but that this was not the
case for hsp-70 (Jones et al. 2001). However,
comparative proteomic analysis of C. elegans mixed
life cycle stages and dauer larvae showed no over-
expression of DAF-21 protein in dauers (Jeong et al.
2009). Why daf-21 mRNA should be so highly
expressed in the dauer stage remains unclear. One
possibility is that daf-21mRNAmay be accumulated
in dauer larvae in readiness for the transition to
normal development, where elevated levels of
DAF-21 could be required to chaperone proteins
required for non-dauer development. Further studies
would need to examine levels of DAF-21 over a time
course, as the animal exits the dauer stage. Additional
evidence for a role for DAF-21 in the dauer pathway
comes from studies of a gain of function daf-21
mutant. These worms bear a single amino acid
substitution (E292K) in DAF-21 and are dauer-
constitutive (Daf-c), i.e. enter the dauer state under
favourable conditions of growth due to a defect in
chemosensory ability. This Daf-c phenotype is
shared with a second mutant, daf-11, which encodes
a protein homologous to transmembrane guanylyl
cyclases. Both the daf-11 and the daf-21 Daf-c
phenotypes can be rescued using an analogue of
cGMP. It was proposed thatDAF-21 was required to
stabilize DAF-11 or another component in the
cGMP pathway (Birnby et al. 2000). A better
understanding of the key client proteins of DAF-21
in C. elegans would help explain the requirement for
Hsp90 in diﬀerent life cycle stages of the nematode.
While studies from this laboratory have failed
to demonstrate a signiﬁcant induction of DAF-21
in C. elegans following heat shock (as quantiﬁed
by immuno-blotting with a speciﬁc antibody)
(Thompson et al. 2001; Devaney et al. 2005), other
studies using in situ hybridization with daf-21
speciﬁc probes have revealed diﬀerences in both the
staining patterns and abundance of daf-21 mRNA
in C. elegans upon heat shock (Inoue et al. 2003).
At normal growth temperatures, DAF-21 is pre-
dominantly localized to the germline of C. elegans, as
detected by antibody staining (Gillan et al. 2009)
as well as in situ hybridization (Inoue et al. 2003). A
genome-wide RNAi screen reported that knock-
down of daf-21 leads to defects in oogenesis (Piano
et al. 2000; Inoue et al. 2006). In more detailed
experiments from this lab, it was shown that one of
the most penetrant phenotypes obtained upon daf-21
(RNAi) was a protruding vulva and sterility in the F1
generation, due to a lack of gonad development
(Gillan et al. 2009). Interestingly, Drosophila Hsp90
is expressed in the germline (Xiao and Lis, 1989) and
in Xenopus, Hsp90 is expressed during oogenesis
suggesting a conserved function between diﬀerent
species (Coumailleau et al. 1995). While the precise
function of Hsp90 in the germline is still poorly
understood, identiﬁcation of DAF-21 client proteins
can help explain mutant phenotypes, as exempliﬁed
by the interaction between the WEE-1.3 kinase and
Hsp90. Here it was shown that DAF-21 indirectly
regulates the meiotic prophase/metaphase transition
during oocyte development through maintaining
the activity of WEE-1.3 (Myt-1 orthologue in
C. elegans), which is involved in cell cycle progression
(Inoue et al. 2006).
The accumulation of DAF-21 in the germline of
C. elegans is interesting in the context of recent
studies, which have described a role for Hsp90 in
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various silencing pathways, including the piRNA and
microRNA (miRNA) pathways (Izumi et al. 2013;
Martinez and Gregory, 2013). These studies link the
original observations of Lindquist and colleagues on
the capacity of Hsp90 to buﬀer environmental change
with a possible molecular mechanism. Altering the
function of Hsp90 in Drosophila by mutation or by
treatment with GA resulted in ﬂies with various
abnormalities of wings and eyes (Rutherford and
Lindquist, 1998). It was proposed that high levels
of cellular Hsp90 buﬀered pre-existing cryptic
variation, which was then expressed when Hsp90
activity was compromised. However, the molecular
mechanisms underlying these observations have
remained elusive. Recent studies have shown that
Hsp90 interacts in the Piwi pathway in Drosophila.
piRNAs are a germline-speciﬁc class of small RNAs
that silence transposons. Inhibition of Hsp90 func-
tion is proposed to inhibit the loading of RNA onto
PIWI proteins (Izumi et al. 2013), resulting in the
activation of transposons in Drosophila and the
appearance of de novo mutations (Specchia et al.
2010; Gangaraju et al. 2011), suggesting one mech-
anism by which Hsp90 may regulate phenotypic
change. Additional studies have implicated Hsp90 in
epigenetic regulation of gene expression via its
interaction with Trithorax (Trx), a chromatin remo-
delling factor (Ruden and Lu, 2008; Tariq et al.
2009). Trx is associated with active transcription and
Hsp90 inhibition degraded Trx and resulted in a
down-regulation in the expression of a number
of genes. Genome-wide studies in Drosophila cells
using chromatin immunoprecipitation showed that
Hsp90 associated with multiple genes and that
these were transcriptionally paused. Inhibition of
Hsp90 released the pause, activating gene expression
(Sawarkar et al. 2012).
Hsp90 is also involved in the loading of small
interferingRNAduplexes (siRNA) andmiRNAonto
argonaute proteins in Drosophila and in human cells;
argonaute proteins are the main components of the
RNA Induced Silencing Complex (RISC). siRNA
and microRNAs can only fulﬁl their function as
post-transcriptional repressors of gene function
(often referred to as the ‘ﬁne-tuners’ of the genome)
if they are successfully loaded onto these complexes
(Iwasaki et al. 2010; Miyoshi et al. 2010). Whether
Hsp90 plays similar roles in nematodes remains to
be seen, but given the phenotypes of daf-21(RNAi)
(F1 sterility, protruding vulva phenotype, lack of
gonad development, reduced brood size) and larval
arrest in a homozygous daf-21 mutant strain, it is an
area which warrants further investigation.
HSP90 IN PARASITIC NEMATODES
In comparison to the information available on
DAF-21 in C. elegans, relatively little is known
about Hsp90 in parasitic species. hsp90 has been
cloned and partially characterized from the ﬁlarial
worm B. pahangi (Bp-hsp90) (Devaney et al. 2005)
and from the clade I parasite T. spiralis (Yang et al.
2013). In common with most other parasitic nema-
todes, lymphatic ﬁlarial worms undergo a heat shock
as part of their life cycle. The infection is transmitted
to humans by the bite of a mosquito carrying the
third stage larvae (L3) in the mouthparts and head.
The L3 enter the lymphatics where they develop
through two moults to adult male and female adult
worms, which can live for approximately 8 years.
Following sexual reproduction, the adult female
releases microﬁlariae into the lymph which then
migrate to the circulatory system, where they provide
a reservoir of infection for the vector (summarized in
Fig. 1B). The transfer of the L3 between vector and
mammalian host is associated with an elevation in
temperature from the ambient (mosquito) to 37 °C
(mammalian host). Using 35S methionine labelling,
an increase in expression of a range of heat shock
proteins, including Hsp90, was observed as L3 were
shifted from 28 to 37 °C (Jecock and Devaney, 1992).
However, there is no evidence to suggest that the
expression of Bp-hsp90 (either mRNA or protein) is
signiﬁcantly increased following exposure of adult
worms to heat shock conditions (Thompson et al.
2001; Devaney et al. 2005), suggesting that most
Bp-hsp90 is constitutively expressed. Parasitic nema-
todes secrete a range of molecules when cultured in
serum-freemedium (the so called excretory-secretory
products or ES), and analysis of the ES of adult
B. malayi demonstrated that B. malayi Hsp90
(Bm-Hsp90) was present (Kumari et al. 1994), a
ﬁnding which has been conﬁrmed in this laboratory
using B. pahangi (Devaney et al. unpublished
observations). Hsp90 is best characterized as a
cytosolic chaperone, but studies on some cancer
cells have shown that it can be expressed at the cell
surface and secreted into medium (Eustace and Jay,
2004; Eustace et al. 2004). Extracellular Hsp90 was
shown to be required for tumour cell invasion via
the chaperoning of matrix metalloproteinases. It is
diﬃcult to envisage an extracellular function for
Bp-Hsp90 in adult B. pahangi, but it could conceiv-
ably be important for chaperoning and folding other
secreted molecules.
While there are many similarities in the molecular
architecture of DAF-21 and Bp-Hsp90 there are
also signiﬁcant diﬀerences in the function of the
molecule in the respective species. As referred to
above, DAF-21 does not bind GA, while Bp-Hsp90
does. The subtle complexities of the Hsp90 machin-
ery in diﬀerent nematodes was demonstrated in a
study which attempted to rescue theC. elegans daf-21
mutant phenotype by heterologous expression of
parasite hsp90 genes (Gillan et al. 2009). Previous
studies had demonstrated the eﬃcacy of inter-species
complementation experiments in transgenic C. ele-
gans, where a parasite gene can rescue the C. elegans
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mutant phenotype and restore wild type traits (Kwa
et al. 1995; Britton andMurray, 2002; Couthier et al.
2004; Massey et al. 2006). However, despite a high
level of amino acid homology (84% identical, 91%
similar), expression of a Bp-hsp90 transgene could
not rescue a C. elegans daf-21 mutant. Similarly,
no rescuewas observed by expression of theBp-hsp90
construct in wild type C. elegans, in which endo-
genous daf-21 levels were reduced by RNAi. In
these experiments, Bp-hsp90 was introduced into
C. elegans by microinjection of a plasmid construct
containing the Bp-hsp90 coding sequence under the
control of the C. elegans daf-21 promoter and 3′UTR
regions, in an attempt to mimic the expression of the
endogenous gene as closely as possible. To conﬁrm
that the parasite gene was eﬃciently transcribed in
C. elegans, injection of a Bp-hsp90 LacZ translational
reporter construct demonstrated that the parasite
Hsp90 was expressed in most tissues of the trans-
formed worms and, importantly, that the B. pahangi
protein expressed inC. elegans bound to GA beads in
a pull-down experiment (Gillan et al. 2009). Despite
these ﬁndings, complementation of the daf-21
mutant or daf-21(RNAi) worms was never observed.
A more successful inter-species rescue was obtained
using hsp90 from H. contortus (Hc-hsp90), a trichos-
trongyloid nematode of sheep, which belongs to the
same clade as C. elegans. Hc-Hsp90 is 88% identical
and 93% similar to DAF-21 and experiments with an
Hc-hsp90 construct provided partial rescue of the
daf-21 mutant phenotypes. As control experiments
had demonstrated that complementation with the
wild-type daf-21 in the same injection cassette
restored the wild type phenotype of the daf-21
mutant worms, a ‘gradient’ of rescue was proposed,
i.e. despite high sequence homology the B. pahangi
transgene was unable to rescue the mutant,Hc-hsp90
was able to confer partial rescue but it required
complementation with the wild-type C. elegans gene
to completely rescue the mutant phenotypes and
restore fertility (see Table 1 for summary). These
results suggest that in metazoans, the ability to
complement Hsp90 function may depend on factors
other than sequence homology; successful rescuemay
require speciﬁc co-chaperones for full function of the
transgene, or alternatively these data may reﬂect
diﬀerence in the ability of the respective Hsp90
proteins to chaperone key client proteins. In contrast
to the studies on nematode Hsp90, other inter-
species complementation experiments using mutant
Saccharomyces cerevisiae have been successful even
when the degree of homology between the respective
hsp90 genes was relatively limited (see Table 2).
Indeed, both C. elegans wild-type daf-21 and human
hsp90b were able to rescue an S. cerevisiae hsp90
mutant despite sharing only 60·5 and 60·3% sequence
homology, respectively. However, in this case com-
plementation required the presence of STI-1/Hop
(Hsp organizing protein) indicating that the ex-
pression of co-chaperone proteins is of primary
importance to the functionality of Hsp90 (Piper
et al. 2003).
HSP90 CO-CHAPERONES IN NEMATODES
The interaction of Hsp90 with client and co-
chaperone proteins is regulated by ATP-induced
conformational changes in Hsp90, resulting in the
folding and activation of substrate or ‘client’ proteins.
Over the years, the number of Hsp90 client proteins
has grown signiﬁcantly and it has been shown to be
essential in the maturation of many diﬀerent types of
protein in mammalian cells, including transcription
factors, steroid receptors, serine/threonine and tyro-
sine kinases. A list of Hsp90 client proteins is curated
by The Picard laboratory (http://www.picard.ch).
Table 1. Summary of hsp90 inter-species rescue experiments in C. elegans. Extracted from Gillan
et al. (2009)
C. elegans H. contortus B. pahangi
Complementation of mutant Yes Partial rescues L2/L3 arrest No rescue
RNAi n/a No rescue No rescue
% id with C. elegans 100% 88% 84%
Table 2. Summary of hsp90 inter-species rescue experiments
in S. cerevisiae. Extracted from Palmer et al. (1995);
Piper et al. (2003); Wider et al. (2009)
Species % id with S. cerevisiae Complementation
Escherichia coli 36% No
Homo sapiens 59% Yes
Trypanosoma cruzi 63% Yes
Plasmodium falciparum 63% Yes
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There are no published data from parasitic nematode
species on the client proteins that require Hsp90 for
function, but there is an extensive list of both
predicted and conﬁrmed clients for DAF-21 (http://
www.wormbase.org). Many of these clients have
homologues in the human system, such as small
ribosomal proteins, serine/threonine kinases and
cyclin-dependent kinases, in addition to some
‘worm-speciﬁc’ proteins, such as those essential for
pharyngeal pumping, a process required for food
intake. While it is likely that at least some C. elegans
client proteins will be similar in other nematodes, the
degree of conservation is currently unknown.
The identiﬁcation and function of co-chaperones
in diﬀerent species is of interest given their import-
ance in the outcome of client protein maturation. For
example, some Hsp90 clients require a select group
of co-chaperones and alternative co-chaperones may
have diﬀerential eﬀects on client proteins (Riggs et al.
2004; Felts et al. 2007; Smith and Toft, 2008). These
ﬁndings are strengthened by evidence that many co-
chaperones display mutually exclusive binding to
Hsp90 (Pratt et al. 2004; Harst et al. 2005; Pearl and
Prodromou, 2006). A study by Johnson and Brown
illustrated the plasticity of the co-chaperone machin-
ery in diverse eukaryotes and showed that the
architecture of the Hsp90/co-chaperone machine
varied in a species-speciﬁc manner. Their results
suggested that with increasing complexity of the
organism, additional co-factors may be required.
While Hsp90 is universally required in metazoans, it
is likely that the Hsp90 complex varies in diﬀerent
tissues/cells. Caenorhabditis elegans was shown to
express orthologues of nine of the ten human Hsp90
co-chaperones used in the directed Psi-BLAST
search against the complete C. elegans genome
(Johnson and Brown, 2009). The only co-chaperone
absent in C. elegans was Cyp40, which was ﬁrst
identiﬁed in mammalian steroid receptor complexes
(Riggs et al. 2004). However, another striking
diﬀerence in C. elegans was shown to occur within
the sequence of the adaptor protein Hop (STI-1 in
C. elegans), which has an essential role in mediating
interactions between Hsp70 and Hsp90. In most
eukaryotes, Hop consists of ﬁve domains: three
tetratricopeptide repeat (TPR) domains and two
dipeptide (DP) repeats, which act as linker
domains, arranged TPR1–DP1–TPR2A–TPR2B–
DP2 (Scheuﬂer et al. 2000). However, C. elegans
STI-1 lacks the TPR1 and DP1 domains (www.
wormbase.org). This is an intriguing ﬁnding as, in
other systems, the TPR1 domain has been shown to
be essential for binding Hsp70, and for linking
Hsp70 with Hsp90 (which binds Hop via TPR2A)
(Scheuﬂer et al. 2000). Hsp70was observed to bind to
C. elegans STI-1 despite the lack of the hypothetical
binding site; however, in the presence of DAF-21,
Hsp70 binding was completely abrogated suggesting
that in C. elegans there may be no requirement for
both chaperones to interact simultaneously, distin-
guishing C. elegans from other species (Gaiser et al.
2009). The lack of the TPR1 domain was also
observed in the closely relatedCaenorhabditis briggsae
and Caenorhabditis remanei. Interestingly, it appears
this atypical Hop is not limited to the Caenorhabditis
genus, as the B. malayi genome contains an ortho-
logue ofC. elegans STI-1, BMA-STI-1 (http://www.
wormbase.org). This protein shares 65·5% amino
acid identity with C. elegans STI-1 and similarly
appears to lack TPR1 and DP1 domains suggesting
that this could be a nematode-wide scenario
(see Fig. 3).
Fig. 3. Comparison of the domain structures of Hop from divergent species. TPR domains are shown in blue and
DP domains in pink. Homologues of Hop show diﬀerences in domain organization. TPR1 and DP1 are absent in the
nematode species C. elegans and B. malayi while only DP1 is lacking in D. melanogaster. All ﬁve domains are present
in H. sapiens and S. cerevisiae. Adapted from Gaisier et al. (2009).
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In 2007, a genome-wide promoter analysis ad-
dressed the tissue-speciﬁc expression of most pro-
teins in C. elegans and showed that DAF-21 was
expressed in many diﬀerent cell types. This analysis
allowed the correlation of DAF-21 expression with
the expression proﬁles of its presumed co-chaperone
proteins (Dupuy et al. 2007). Analysing the diﬀer-
ential expression of DAF-21 and its co-chaperones
allows for some speculation on the cellular activity of
theHsp90/co-chaperone complexes, as it is likely that
tissue localization corresponds to function (data
accessed through www.wormbase.org). For example,
co-chaperones P23 (ZC395.1), Hop (STI-1) and
FKB-6 were all shown to be ubiquitously expressed
in C. elegans, whereas PP5 (PPH-5) and CDC-37 are
expressed only in the intestine and embryo respect-
ively, suggesting amore speciﬁc role. Perhaps the best
example of cellular location correlating with function
is illustrated by the expression pattern of the TPR-
containing cofactor UNC-45 (uncoordinated), which
is expressed in body wall muscle, intestinal muscle
and vulval muscles. In C. elegans, the 95 rhomboid-
shaped body wall muscle cells comprise one of the
major tissues of the adult worm (www.wormatlas.
org). Down-regulation of UNC-45 leads to paralysis
via decreased myosin assembly, whereas an excess of
UNC-45 results in myosin accumulation, both of
which result in defective myoﬁbril organization
(Barral et al. 2002; Landsverk et al. 2007). The
details of how UNC-45 and DAF-21 work together
are still unclear, although it has been reported that
UNC-45 interacts with Hsp90 via a TPR domain
(Russell et al. 1999; Scheuﬂer et al. 2000; Barral
et al. 2002) and myosin motor domains through its
COOH-terminal regions (Barral et al. 1998, 2002).
Elegant studies by Ni et al. demonstrated that
DAF-21 and UNC-45 interact in pull-down experi-
ments using C. elegans lysates and proposed that this
interaction might have an inhibitory eﬀect on the
myosin-chaperoning activity of UNC-45 (Ni et al.
2011).
Online sources (http://www.wormbase.org) dem-
onstrate that C. elegans encodes 80 TPR proteins, so
perhaps the fact that only nine are known homo-
logues of human Hsp90 co-chaperones is surprising
(for comparison, the proteome of S. cerevisiae
contains about 25 proteins with TPR domains,
seven of which are conﬁrmed to interact with either
Hsp90 or Hsp70). In a recent study, Haslbeck et al.
analysed previously uncharacterized TPR proteins,
known to be associated with the Hsp90/Hsp70
complex. The entire proteome of C. elegans was
analysed and scores were given to each protein based
on the level of homology to known co-chaperone
TPR proteins of Homo sapiens, S. cerevisiae and
C. elegans. The proteins with the highest score for
potential binding to Hsc70/Hsp70 and Hsp90 were
the tenC. elegansTPRproteins used in the sample set
(SGT-1, UNC-45, FKB-6, PPH-5, STI-1, HIP-1,
CHN-1, C56C10.10/AIP-1, C17G10.10/CNS-1).
In addition, three uncharacterized C. elegans open-
reading frames with homologues in Drosophila or
humans emerged as possible Hsp90 interactors. Two
of these, C34B2.5 and ZK370.8 were shown to bind
both Hsc70 and DAF-21 with low micromolar
aﬃnities; mutation of amino acids in the Hsp90
binding site for TPR proteins (EEVD sequence) was
shown to disrupt the interaction. Interestingly, this
study demonstrates that themajority of TPR proteins
in C. elegans have no binding aﬃnity for DAF-21
(Haslbeck et al. 2013).
HSP90 AS A DRUG TARGET IN NEMATODES
The realization that Hsp90 acted as a chaperone for
various oncogenic proteins led to a major eﬀort to
develop novel small molecule inhibitors of Hsp90 for
use in various tumours (Neckers et al. 1999). More
recently the potential of Hsp90 inhibitors as novel
chemotherapeutic agents for various parasitic infec-
tions has been studied (see other articles in this
special issue). As referred to previously, there is a
need for novel drugs to treat humans and animals
infected with helminth parasites and studies in vitro
have shown a dependence on Hsp90 in parasitic
nematodes (Devaney et al. 2005) and in the trematode
parasite Schistosoma japonicum (Wenkert et al. 2010).
The design of new anthelmintics generally centres on
attempts to establish and exploit molecular targets
that are exclusive to the parasite, with the aim of
minimizing potential damage to the host. Although
this approach can be successful, an alternative course
is to target a common pathway shared by the
infectious agent and the host, which has evolved
over time to perform diﬀerent functions unique to the
respective species. The beneﬁts of focusing drug
discovery on such pathways are two-fold; the scope
for identifying new targets is broadened and not
conﬁned to parasite-speciﬁc molecules, many of
which are hypothetical proteins of unknown func-
tion, and the ubiquity of such molecules in other
systems may allow for drugs designed in this way to
be used in other parasitic infections. The repurposing
of compounds developed to treat other conditions is
an attractive proposition for drug development for
neglected tropical diseases, where the potential to
recoup drug development costs is limited. In this
respect, Hsp90 inhibitors have been shown to be
eﬀective against a variety of tropical pathogens
including Plasmodium (Kumar et al. 2003; Shahinas
et al. 2010, 2013), Trypanosoma (Pallavi et al. 2010)
and Leishmania (Petersen et al. 2012).
Recent studies from this laboratory have focused
on the potential of Hsp90 inhibitors as macroﬁlar-
icidal agents in ﬁlarial infection. Currently, the drugs
used to control ﬁlarial nematodes in mass drug
administration (MDA) programmes, such as diethyl-
carbamazine (DEC) and ivermectin, largely target
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the circulating microﬁlariae (Mf), resulting in re-
duced transmission rates. However, Mf repopulate
the circulation necessitating continued treatment
over the long reproductive lifespan of adult worms,
incurring signiﬁcant costs for control programmes
and increasing the chances of resistance emerging
(Prichard et al. 2012). It has long been a goal ofWHO
to identify a suitable drug that kills adult ﬁlarial
worms but, to date, no such agent has been developed
(Molyneux et al. 2003). At higher concentrations
of drug, DEC can have macroﬁlaricidal activity,
although in most long-term studies, Mf were shown
to re-emerge in the blood of some patients, 1–5 years
post-treatment. This suggests either that a pro-
portion of adult worms survived DEC treatment
and recoverMf production ormay reﬂect re-infection
(Terhell et al. 2003). Targeting the Wolbachia
intracellular endosymbiont of many pathogenic
ﬁlarial worms with doxycycline remains the most
promising new therapy that aﬀects adult worms.
However, this antibiotic is contraindicated in preg-
nant women and children and prolonged dosing is
not ideal for MDA, but the search continues for a
more satisfactory antibiotic (Hoerauf, 2008). While
the B. malayi genome may yet illuminate novel
parasite-speciﬁc drug targets, we have previously
identiﬁed a requirement for Hsp90 as a possible weak
spot in ﬁlarial nematodes. The prototype Hsp90
inhibitor, GA, a naturally occurring benzoquinone
ansamycin, binds the N-terminal ATP pocket of
Hsp90 disrupting its function and resulting in the
degradation and/or inhibition of client proteins. In
initial studies, in vitro exposure of B. pahangi adult
female worms to 1 μM GA (a concentration chosen as
it inhibits mammalian Hsp90 activity) was shown to
result in a signiﬁcant reduction in Mf production
from adult worms after 24 h and by 48 h, Mf release
had ceased completely (Devaney et al. 2005). As well
as inhibiting Mf output, GA was shown to kill adult
worms, as after 7 days of exposure to drug, 100% of
adult female worms were dead. GA probably has a
speciﬁc eﬀect on adult worms (as well as inhibition of
Mf output), as further experiments demonstrated
that adult males were also killed by exposure to 1·0 μM
GA. As referred to above, most species of ﬁlarial
worms are known to harbour endosymbiotic bacteria,
and to ensure that these eﬀects were not a result
of GA targeting the Wolbachia of B. pahangi, the
experiments were repeated using the Wolbachia-free
species Acanthocheilonema viteae and similar results
were obtained. Comparable data were produced
by Wenkert et al. who tested GA and a number of
GA-derivatives against adult B. malayi in vitro. In
their study, all four derivatives tested were active at
concentrations down to 500 nM. While these results
show promise, GA suﬀers from limitations as a
chemotherapeutic agent due to unacceptable levels of
hepatoxicity and would not be suitable for use in
ﬁlarial infection. Thus most recent studies on Hsp90
inhibitors have focused on novel small molecule
inhibitors (Wenkert et al. 2010).
In subsequent studies, we investigated whether
members of the purine-scaﬀold series of Hsp90
inhibitors, developed by the Chiosis laboratory
(Chiosis and Tao, 2006; Taldone et al. 2011),
would have activity against adult B. pahangi. In
initial experiments, a ﬂuorescence polarization (FP)
assay, originally developed as a high-throughput
screen for the detection of small molecule inhibitors
of Hsp90 in tumour cells, was adapted to Brugia sp.
(Taldone et al. 2010). The assay is based on the
ability of small molecules to compete with the
binding of ﬂuorescently labelled GA to Hsp90 in
cellular homogenates, thus negating the need for the
production of puriﬁed recombinant protein as well as
enabling investigation of Hsp90 in its native confor-
mation. Previous studies had demonstrated that
Hsp90 in tumour cells is present in multi-chaperone
complexes with high ATPase activity and a higher
aﬃnity for N-terminal inhibitors compared with
Hsp90 from normal cells, where it is present in a
latent formwith a reduced aﬃnity for these inhibitors
(Kamal et al. 2003). Subsequent studies conﬁrmed
this ﬁnding and showed that Hsp90-speciﬁc pull-
downs using the purine scaﬀold compound, PU-H71
conjugated to a solid support, identiﬁed a complex of
interacting proteins from tumour cells (Moulick et al.
2011). Interestingly, the aﬃnity ofBp-Hsp90 for GA
was shown to be similar to tumour cell Hsp90 in the
FP assay, while extracts of C. elegans did not show
signiﬁcant binding, consistent with previous results.
In addition, some selectivity was noted in the binding
of the purine-scaﬀold compounds to Bp-Hsp90
(Taldone et al. 2010); a 3-fold change in selectivity
ratio was observed between PU-H71 and PU-WS10,
two compounds with almost identical structure,
suggesting that the FP assay could identify molecules
which may speciﬁcally target parasite Hsp90.
In more recent work from this laboratory, we
examined whether Hsp90 inhibitors might aﬀect
adult worms in vivo (Gillan et al. 2014). For this
purpose we selected an isoxazole inhibitor, NVP-
AUY922, which had previously been demonstrated
to exhibit anti-tumour activity in a mouse xenograft
tumour model (Eccles et al. 2008; Garon et al. 2013).
Experiments in vitro had shown NVP-AUY922 to
be remarkably active against both adult worms
and Mf at very low concentrations, killing Mf at
concentrations down to 1·56 nM and 50% of adult
worms at 25 nM. Using a model system in which
adult B. pahangi worms are transplanted into the
peritoneal cavity of mice (Devaney et al. 2002), we
demonstrated that administration of three doses
of NVP-AUY922 at 50mg kg−1 eﬀectively killed
adult worms (Gillan et al. 2014). No weight loss or
other deleterious eﬀects were observed in treated
animals over the time course. While these experi-
ments provide proof of principle that inhibition of
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Hsp90 is lethal to adult ﬁlarial worms in vivo, further
experiments are required with diﬀerent routes of
drug administration and diﬀerent doses of drug.
CONCLUSIONS
Recent studies on the free-living model nematode
C. elegans have shed new light on the mechanisms of
Hsp90 function in metazoans, particularly in relation
to the tissue-speciﬁc requirement for certain co-
chaperones. Additional studies will be required to
fully explain the apparent resistance of C. elegans to
Hsp90 inhibitors and the molecular mechanisms
underlying this phenomenon. However, given the
studies reviewed above it is likely that the function of
Hsp90 diﬀers between free-living nematodes and
their parasitic counterparts. It is possible that part of
this discrepancy will be explained by diﬀerences in
the Hsp90 interactome in free-living and parasitic
species, such as ﬁlarial worms, perhaps equivalent
to the diﬀerences in Hsp90 function in normal
versus tumour cells. While aspects of their basic
biology, such as moulting, are conserved amongst
all nematodes, there are signiﬁcant diﬀerences be-
tween free-living and parasitic species in life cycles,
modes of transmission, reproduction and dependence
on hosts. As momentum to eliminate neglected
tropical diseases grows, the prospect of repositioning
existing drugs is an appealing one. However, while
preliminary results show that chemical inhibition of
Hsp90 is lethal to adult ﬁlarial worms, further
research is required to determine whether Hsp90
truly represents an ‘Achilles heel’ in ﬁlarial nema-
todes, suitable for exploitation as a chemotherapeutic
target.
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